Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Among the many things columnist Candace Semien had to learn while living with lupus were the types and function of various ...

Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.

Columnist Marisa Zeppieri faces a dilemma when she's asked "How are you?" One choice is to answer truly, another to answer superficially.

People often fail to acknowledge the type of grief that comes with chronic illness. It's time to change that, columnist Marisa Zeppieri says.

Columnist Candace Semien is putting her body on a performance improvement plan so that she handles the Job of Life as best she can.

As we flip the page to a new year, the pull of hustle culture on social media hasn’t seemed to change. Messages urge us to do more, achieve more, and push harder. But for those of us living with lupus ...

The FDA granted fast track designation to SC291 as a potential treatment for hard-to-manage systemic lupus erythematosus (SLE).

Columnist Marisa Zeppieri offers tips for developing gratitude that she's found useful, even while living with lupus.

Patient screening has begun in the Ntrust-1 clinical trial of NKX019, a potential CAR cell therapy for treatment-resistant lupus nephritis.

A recent beach adventure prompts columnist Candace Semien to reflect on the value of doing something for the first time.

Stopping glucocorticoid therapy after achieving remission did not increase the risk of symptom flare-ups in SLE patients, data showed.